*NEWS: Med-Device Startup CathWorks Raises $30 Million
A med-device company with HQ in Israel and an outpost in Aliso Viejo has raised $30 million in a Series C round led by Deerfield Management.
CathWorks announced the completion of the round in a press release. Its technology known as “FFRangio,” based on FFR, recently received FDA clearance.
FFR, fractional flow reserve, is a technique used in coronary catheterization procedures. It measures pressure differences to determine whether oxygen is being delivered to the heart muscle.
The system “quickly and precisely” delivers objective FFR guidance needed to optimize therapeutic decisions for coronary patients, according to the release.
It is non-invasive and performed during coronary angiography procedures, without adding additional clinical risk or per-procedure costs, according to the company.